Theophylline and prostaglandin E2 on duodenal bicarbonate secretion: role for 5'-cyclic adenosine monophosphate.
Cyclic adenosine monophosphate (cAMP) has been implicated as an intracellular "second" messenger in duodenal mucosal bicarbonate secretion in animals. The purpose of this study was to determine whether cAMP may mediate duodenal mucosal bicarbonate secretion in humans. In healthy volunteers, a 4-cm segment of proximal duodenum was isolated from gastric and pancreaticobiliary secretions. Either the phosphodiesterase inhibitor theophylline, prostaglandin (PG) E2, or a combination thereof was administered topically to the isolated duodenal mucosa. Theophylline (10(-2) mol/L) and PGE2 (10(-5)-10(-4) mol/L) each significantly increased bicarbonate secretion and transmucosal potential difference. Moreover, when theophylline and PGE2 were administered in combination, the duodenal bicarbonate output was additive compared to either agent alone. When theophylline was infused with increasing doses of PGE2, the dose-response curve was shifted to the left. Furthermore, increases in bicarbonate secretion and transmucosal potential difference were correlated significantly. These results suggest that cAMP may act as an intracellular mediator of human duodenal mucosal bicarbonate secretion.
Mu
J Z
JZ
Department of Medicine, UCSD Medical Center, California.
Hogan
D L
DL
Koss
M A
MA
Isenberg
J I
JI
D000328:Adult; D001639:Bicarbonates / Q000378:metabolism*; D000242:Cyclic AMP / Q000502:physiology*; D015232:Dinoprostone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004386:Duodenum / Q000378:metabolism* / Q000502:physiology; D004594:Electrophysiology; D006801:Humans; D007413:Intestinal Mucosa / Q000502:physiology; D008297:Male; D013806:Theophylline / Q000494:pharmacology*
D001639:Bicarbonates; D004338:Drug Combinations; D013806:Theophylline; D000242:Cyclic AMP; D015232:Dinoprostone